Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Outlook Therapeutics Inc. buy DomRuinart

Outlook Therapeutics Inc.
Start price
€0.57
18.08.26 / 50%
Target price
€2.50
18.08.27
Performance (%)
9.96%
Price
€0.63
12:02
Summary
This prediction is currently active. With a performance of 9.96%, the BUY prediction by DomRuinart for Outlook Therapeutics Inc. is trending in the right direction. This prediction currently runs until 18.08.27. The prediction end date can be changed by DomRuinart at any time. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w
Outlook Therapeutics Inc. 9.96%
iShares Core DAX® -0.874%
iShares Nasdaq 100 -0.381%
iShares Nikkei 225® -1.676%
iShares S&P 500 -0.655%

According to DomRuinart what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by DomRuinart for this prediction

In the thread Outlook Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 9.96%
Target price 2.500
Change
Ends at

Buy mit Kursziel 2,5

DomRuinart 
0
Report Share
18.08.26